Association of socioeconomic status with hypertension prevalence and control in Nanjing: a cross-sectional study. 2022

Zhenzhen Qin, and Chao Li, and Shengxiang Qi, and Hairong Zhou, and Jie Wu, and Weiwei Wang, and Qing Ye, and Huafeng Yang, and Chenchen Wang, and Xin Hong
Department of Non-Communicable Disease Prevention, Nanjing Municipal Center for Disease Control & Prevention, 2, zizhulin, Nanjing, 210003, China.

The role of socioeconomic status (SES) on hypertension prevalence and hypertension control has gotten much attention but with conflicting results. This paper aimed to quantify the association of SES with both hypertension prevalence and hypertension control rate in Nanjing, China. A community-based cross-sectional study was conducted using multistage random sampling on 60,283 adults aged more than 18 years between March 2017 and June 2018. Hypertension was defined as systolic blood pressure (BP) ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg or self-reported diagnosis of hypertension or respondent's report of taking antihypertensive medications. The controlled hypertension was defined by systolic BP < 140 mmHg and diastolic BP of < 90 mmHg among the subjects that self-reported exhibiting hypertensive and taking antihypertensive medications. The associations between SES with hypertension prevalence and hypertension control were quantified using generalized mixed model regression analysis and reported as odds ratios (ORs) and 95% confidence interval (CI). There was a high prevalence of subjects with primary educational level (49.6%) or unemployed and retired (49.5%) or lower annual household income level (44.9%) in each SES group, respectively. After adjustments for potential confounding factors, there were higher odds of hypertension among those with primary educational level (OR = 1.56), but lower odds for controlled BP (OR = 0.51). Higher odds of hypertension could be found among unemployed and retired, and higher odds of controlled BP was observed in the mental laborers or students (OR = 1.30), compared with the other categories, respectively. The lower-income group was more likely to be hypertensive (OR = 1.35) and less likely to have controlled hypertension (OR = 0.73). Socioeconomic status played an important role in hypertension prevalence and hypertension control among adults in Nanjing, China. Strategies for hypertension prevention and control should especially focus on people in the vulnerable lower SES groups.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D012923 Social Class A stratum of people with similar position and prestige; includes social stratification. Social class is measured by criteria such as education, occupation, and income. Caste,Social Gradients,Socioeconomic Level,Socioeconomic Status,Middle Class Population,Castes,Class, Social,Gradient, Social,Level, Socioeconomic,Middle Class Populations,Population, Middle Class,Social Classes,Social Gradient,Socioeconomic Levels,Status, Socioeconomic
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences

Related Publications

Zhenzhen Qin, and Chao Li, and Shengxiang Qi, and Hairong Zhou, and Jie Wu, and Weiwei Wang, and Qing Ye, and Huafeng Yang, and Chenchen Wang, and Xin Hong
December 2025, BMJ open,
Zhenzhen Qin, and Chao Li, and Shengxiang Qi, and Hairong Zhou, and Jie Wu, and Weiwei Wang, and Qing Ye, and Huafeng Yang, and Chenchen Wang, and Xin Hong
October 2015, JRSM open,
Zhenzhen Qin, and Chao Li, and Shengxiang Qi, and Hairong Zhou, and Jie Wu, and Weiwei Wang, and Qing Ye, and Huafeng Yang, and Chenchen Wang, and Xin Hong
October 2023, BMJ open,
Zhenzhen Qin, and Chao Li, and Shengxiang Qi, and Hairong Zhou, and Jie Wu, and Weiwei Wang, and Qing Ye, and Huafeng Yang, and Chenchen Wang, and Xin Hong
January 2022, Frontiers in psychiatry,
Zhenzhen Qin, and Chao Li, and Shengxiang Qi, and Hairong Zhou, and Jie Wu, and Weiwei Wang, and Qing Ye, and Huafeng Yang, and Chenchen Wang, and Xin Hong
June 2014, Arthritis care & research,
Zhenzhen Qin, and Chao Li, and Shengxiang Qi, and Hairong Zhou, and Jie Wu, and Weiwei Wang, and Qing Ye, and Huafeng Yang, and Chenchen Wang, and Xin Hong
November 2013, Rheumatology (Oxford, England),
Zhenzhen Qin, and Chao Li, and Shengxiang Qi, and Hairong Zhou, and Jie Wu, and Weiwei Wang, and Qing Ye, and Huafeng Yang, and Chenchen Wang, and Xin Hong
October 2023, European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry,
Zhenzhen Qin, and Chao Li, and Shengxiang Qi, and Hairong Zhou, and Jie Wu, and Weiwei Wang, and Qing Ye, and Huafeng Yang, and Chenchen Wang, and Xin Hong
December 2023, BMC women's health,
Zhenzhen Qin, and Chao Li, and Shengxiang Qi, and Hairong Zhou, and Jie Wu, and Weiwei Wang, and Qing Ye, and Huafeng Yang, and Chenchen Wang, and Xin Hong
May 2021, American journal of health promotion : AJHP,
Zhenzhen Qin, and Chao Li, and Shengxiang Qi, and Hairong Zhou, and Jie Wu, and Weiwei Wang, and Qing Ye, and Huafeng Yang, and Chenchen Wang, and Xin Hong
January 2022, Frontiers in psychiatry,
Copied contents to your clipboard!